NetworkNewsBreaks Archive - Page 2066 of 2081

ThursdayNov 03, 2016 11:25 am

Moxian, Inc.’s (MOXC) Strengthens B2C Reach via Mobile Apps

With the exponential value of mobile marketing for business, organizations are exploring innovative ways to better reach their audiences. Effective business to Consumer (B2C) marketing encompasses a wide variety of tools to achieve this goal, including social media, specifically designed content for use on mobile device, hyper-targeted ads, and more. China-based Moxian (OTCQB: MOXC) operates within this realm, offering social media marketing and promotion platforms via two mobile friendly applications: the Moxian+ Business app and the Moxian+ User app. “Since social media in particular is widely used on mobile devices, companies now need to make sure that all aspects of…

WednesdayNov 02, 2016 10:51 am

Verastem, Inc. (VSTM) Licenses Infinity Pharmaceuticals’ (INFI) Cancer Treatment Candidate

Verastem, Inc. (NASDAQ: VSTM) and Infinity Pharmaceuticals (NASDAQ: INFI) are trading higher after the companies announced that Verastem has licensed exclusive worldwide rights to develop and commercialize Infinity's oncology product candidate duvelisib for the treatment of hematologic cancers, including chronic lymphocytic leukemia (CLL), indolent non-Hodgkin lymphoma (iNHL) and T cell lymphomas. To view the full press release, visit: http://nnw.fm/WM3ut About Verastem, Inc. Verastem, Inc. (NASDAQ:VSTM) is a biopharmaceutical company focused on discovering and developing drugs to improve outcomes for patients with cancer. Verastem is currently developing duvelisib, a dual inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, which has successfully met its…

WednesdayNov 02, 2016 10:50 am

Agora Holdings, Inc. (AGHI) Continues to Advance FRAME Social Media Management Tool

Agora Holdings (OTC: AGHI) continues to update its FRAME social media management software offered by its Geegle Media subsidiary, and most recently announced its plans to move the platform from the private market to a unique “do it yourself” tool for small and medium-sized businesses. “Originally launched in September of this year, FRAME differentiates itself from the competition by offering free use for non-commercial users. In an effort to provide the best experience possible to both free and paid users, FRAME also offers an extensive reporting system that allows users to monitor the performance metrics of each of their posts…

WednesdayNov 02, 2016 10:49 am

Cherubim Interests, Inc. (CHIT) Sharply Reduces Debt, Shares Lower

Cherubim Interests (OTC: CHIT) this morning announced the elimination of a “significant” portion of its High Interest Convertible Debt and Principal Debt in what company CEO Patrick Johnson says is the result of an aggressive debt reduction campaign. “We have been aggressively addressing debt reduction over the past twelve months. These debts included convertible note instruments to extremely high interest lenders, which upon conversion causes dilution that adversely affects the stock price," he stated in the news release. "The approximate debt as of August 31, 2015, was $1,180,000 and to better position the company for uplist we have retired over…

WednesdayNov 02, 2016 10:47 am

MicroVision, Inc. (MVIS) Posts Q3, Nine-Month Revenue Growth, Reaffirms FY Sales; Shares Surge

MicroVision (NASDAQ: MVIS) is up 10% in morning trade after the company posted third-quarter revenue of $4.0 million and a 61% increase in nine-month revenue to $11.9 million. Net loss for the third quarter of 2016 was $4.1 million, or $0.08 per share, compared to $3.5 million, or $0.07 per share, for the same quarter a year ago. MicroVision reaffirmed its revenue guidance for full-year 2016, with expectations at the high end of $14.5 million and $15 million. The innovator of ultra-miniature projection display and sensing technology also announced its plans to roll-out three new scanning engine products starting in…

WednesdayNov 02, 2016 10:45 am

EyeGate Pharmaceuticals, Inc. (EYEG) Records Q3 Revenues; Shares Higher

EyeGate Pharmaceuticals (NASDAQ: EYEG) this morning reported third-quarter revenue of $0.274 million, compared with no revenue in the third quarter of 2015. Net loss for the quarter was $3.3 million, compared with a loss of $1.3 million in the comparable quarter of last year. The company attributes the loss to its confirmatory phase 3 trial of EGP-437 in anterior uveitis, its phase 1b/2a trial for post-cataract surgery inflammation and pain and the continued development of the EyeGate OBG, as well as increased R&D, general and administrative and other expenses supporting these activities. To view the full press release, visit: http://nnw.fm/1JApy…

TuesdayNov 01, 2016 2:06 pm

Virtual Reality is Essential Component of eXp World Holdings, Inc.’s (EXPI) Agent-Owned Cloud Brokerage™

The virtual reality (VR) market is expected to top $126 billion by 2020, and for eXp World Holdings (OTCQB: EXPI), the fruits of this technology for use in the real estate industry are already apparent. The company’s Agent-Owned Cloud Brokerage™ division, eXp Realty, is a growing network of real estate professionals that use cloud-based technologies and an advanced VR platform to hold meetings, exchange ideas, take online classes, conduct business and more. “For years, virtual or augmented reality was the stuff of science fiction … But with rapid technological advancements ... virtual reality has now stepped beyond the realm of…

TuesdayNov 01, 2016 2:04 pm

Gold Lakes Corp. (GLLK) Shares Spike on Submission of Exploration Work Permit in Ontario

Shares of Gold Lakes Corp. (OTCQB: GLLK) are up nearly 20% in late-morning trade following word the company has submitted the exploration work permit plan to the Ontario Ministry of Northern Development and Mines (MNDM). The exploration stage Blue-Sky company said it hopes to initiate phase 2 of the exploration program, which will entail assaying and diamond drilling of geological and geophysical targets of up to 10 holes totaling 3,000 meters, in upcoming weeks. To view the full press release, visit: http://nnw.fm/SBgf1 About Gold Lakes Corp. Gold Lakes Corp. is an exploration stage Blue Sky company that specializes in acquiring…

TuesdayNov 01, 2016 2:01 pm

PharmaCyte Biotech (PMCB) Files Request for Pre-IND of Pancreatic Cancer Clinical Trial; Shares Climb

PharmaCyte Biotech (OTCQB: PMCB) is trading higher after the clinical-stage biotech announced its first steps toward regulatory approval in the U.S. of the company’s therapy for inoperable pancreatic cancer (LAPC). The company has filed a request for a pre-IND meeting with the U. S. Food and Drug Administration (FDA) for its planned clinical trial designed to meet a clear unmet medical need for those whose cancer no longer responds after 4-6 months of treatment with the combination of Abraxane® plus gemcitabine. The trial will be open-label and multi-site in nature, with sites in the U.S. and Europe. To view the…

TuesdayNov 01, 2016 11:22 am

Skyline Medical, Inc. (SKLN) Inks UK Distribution Deal with GLG Pharma; Shares Surge

Shares of Skyline Medical (NASDAQ: SKLN) are up 27% after the producer of the FDA-approved STREAMWAY® System announced its distribution agreement granting GLG Pharma, LLC (“GLG”) exclusive rights to market and distribute the STREAMWAY® System in the UK. STREAMWAY System is the company’s direct-to-drain fluid disposal system designed to automate the collection, measurement and disposal of waste fluids in medical settings. To view the full press release, visit: http://nnw.fm/mF2cy About Skyline Medical Inc. Skyline Medical Inc. produces a fully automated, patented, FDA-cleared, waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks